tirzepatide gastroparesis case report A newly published series reports that GLP-1 receptor agonists (like semaglutide and tirzepatide) may significantly improve symptoms in patients with mast cell activation syndrome (MCAS), even in those without diabetes or Diabetes and Gastroparesis: New Concepts

muciniphila -derived bEVs significantly protect streptozotocin (STZ)-induced diabetic mice by regulating glucose homeostasis, attenuating oxidative stress, and inducing immune tolerance, thereby effectively reducing blood glucose levels and ameliorating insulin resistance

But you said you stopped dieting

As an antioxidant, it prevents damage to important cellular components that arise due to reactive oxygen species like free radicals and peroxide

Its essential to consult with a healthcare professional to determine the safety and appropriateness of B12 injections in such cases

They can advise you based on your health history and goals

SURPASS-1 compared tirzepatides different doses to placebo and demonstrated superiority in HbA1c reduction with each dose comparison